Keyphrases
Cervical Cancer
100%
Chemoradiotherapy
69%
Radiotherapy
45%
Density Functional Calculations
37%
Cervical Cancer Patients
36%
Brain Metastases
34%
Clinical Response
34%
La2CuO4
34%
Locally Advanced
34%
Pada
34%
Indonesia
30%
AgNOR
29%
Muon
26%
High Dose
23%
Radiation Response
22%
Jakarta
20%
Stadium
20%
Overall Survival
20%
Whole Brain Radiotherapy
19%
Prognostic Factors
19%
Non-doped
17%
Pyrochlore Iridate
17%
Doped System
17%
Locally Recurrent
17%
P70S6K
17%
Coulomb Potential
17%
Muon Spin Rotation
17%
Spin Alignment
17%
High-Tc Cuprates
17%
Muon Sites Estimation
17%
Misalignment Study
17%
P53 Protein Expression
17%
Acute Non-lymphocytic Leukemia
17%
Chemoradiotherapy Response
17%
Akt Protein
17%
Major Vault Protein
17%
Protein Index
17%
Graded Prognostic Assessment
17%
Recursive Partitioning Analysis
17%
Definitive Radiation
17%
Radical Operation
17%
Patient Survival Rate
17%
Nested Case-control Study
17%
Spin Density
17%
Hippocampal Sparing
17%
Hole Doping
17%
Common Cancers
17%
Bone Marrow
17%
Hospital-based Cancer Registry
17%
Prognostic Score
17%
Medicine and Dentistry
Radiation Therapy
77%
Cervical Cancer
69%
Brain Metastasis
34%
Malignant Neoplasm
27%
Chemoradiotherapy
25%
Radiation Response
22%
Uterine Cervix
20%
Intensity Modulated Radiation Therapy
20%
Overall Survival
20%
Neoplasm
20%
Prognostic Factor
19%
Whole Brain Radiotherapy
19%
Prognostic Assessment
17%
Recursive Partitioning
17%
Survival Rate
17%
Drug Megadose
17%
Cancer Registry
17%
Dosimetry
17%
Preoperative Radiotherapy
17%
Rectum Cancer
17%
Squamous Cell Carcinoma
17%
Nucleolus Organizer Region
17%
Nasopharynx Carcinoma
17%
Nasopharynx Cancer
17%
Parametrium
13%
Implant
13%
Cancer
13%
Mitotic Index
12%
Lymph Node
12%
Protein P53
11%
Pyrazinamide
11%
Circadian Rhythm
11%
Side Effect
9%
Acute Lymphoblastic Leukemia
8%
Tumor Cell
8%
Minimal Residual Disease
6%
Recurrent Disease
6%
Iridium 192
6%
External Beam Radiotherapy
6%
Melatonin
5%
Deterioration
5%
Hippocampus
5%
Combination Therapy
5%
Pelvis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Uterine Cervix Cancer
86%
Chemoradiation Therapy
73%
Protein P53
52%
Malignant Neoplasm
41%
Brain Metastasis
34%
Neoplasm
27%
Fenofibrate
26%
Overall Survival
21%
Lung Resistance Protein
17%
Squamous Cell Carcinoma
17%
Nasopharynx Cancer
17%
Biological Marker
17%
Dosimetry
17%
Protein Kinase B
17%
Cancer Registry
17%
Nasopharynx Carcinoma
17%
Survival Rate
17%
Chemotherapy
14%
Pyrazinamide
11%
Side Effect
9%
Melatonin
8%
Mitogen Activated Protein Kinase
8%
Combination Therapy
5%
Deterioration
5%
Inflammation
5%
Haematoxylin
5%
Eosin
5%
Acute Lymphoblastic Leukemia
5%
